Researchers say women who took Zometa along with hormone drugs reduced their risk of breast cancer by 35 percent.
"It sounds as if it will the real wave of the future in terms of breast cancer," Marshall said.
The findings are so promising that some doctors are saying they will start prescribing Zometa for early stage breast cancer patients immediately.